Answers are grounded in this paper and cite their sources.
We recently reported that the treatment with nanoparticles (NPs) loaded with tolerogenic cytokines suppressed the manifestations of lupus-like disease induced by the transfer of donor CD4 + T cells from DBA/2 mice into (C57BL/6 × DBA/2)F 1 (BDF1) mice. Although the protective effects were ascribed to the induction of adaptive CD4 + and CD8 + T regulatory cells, the results suggested that another population of immune cells could be involved. Here we report that NK cells critically contribute to the protection from lupus-like disease conferred by NPs to BDF1 mice, and that this effect is TGF-β-dependent.
No takes yet. Share an insight, caveat, or question.
Horwitz et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: